【レポートの概要(一部)】
1. Introduction to Orphan Drug
2. Favorable Market Dynamics for Orphan Drugs Commercialization
2.1 Economic Viability
2.2 Drug Patent Expiry
2.3 Financial & Non-Financial Incentives
2.4 Patent & Market Exclusivity
2.5 R&D Investment
3. Global Orphan Drug Market Overview
4. Global Orphan Drug Market Segment Analysis
4.1 Biological & Non-Biological Orphan Drugs
4.2 Therapeutic Segmentation
4.3 Regional Segmentation
5. Global Orphan Drug Clinical Pipeline Overview
6. US Orphan Drug Market Overview
6.1 Orphan Drug Designation Criteria
6.2 Market Overview
6.3 Reimbursement Policy
7. Europe Orphan Drug Market Overview
7.1 Orphan Drug Designation Criteria
7.2 Market Overview
7.3 Reimbursement Policy
8. Asia Orphan Drug Market Overview
8.1 Orphan Drug Designation Criteria
8.2 Market Overview
8.3 Reimbursement Policy
9. FDA Regulation for Clinical Trials Orphan Designated Drugs
9.1 Content & Format of a Request for Written Recommendations
9.2 Provision for Granting & Refusing Written Recommendations
9.3 Content and Format of a Request for Orphan Drug Designation
9.4 Verification of Orphan Drug Status & Resident Agent for Foreign Sponsor
9.5 Timing of Requests for Orphan Drug Designation & Designation of Already Approved Drugs
9.6 Deficiency Letters and Granting Orphan Drug Designation
9.7 Refusal to Grant Orphan Drug Designation
9.8 Amendment & Change in Ownership to Orphan Drug Designation
9.9 Publication & Revocation of Orphan Drug Designations
9.10 Annual Reports of Holder of Orphan Drug Designation
9.11 Scope & FDA Recognition of Orphan Drug Exclusive Approval
9.12 Protocols for Investigations & Availability of Information
10. EMA Regulations for Clinical Trials of Orphan Designated Drugs
10.1 Committee for Orphan Medicinal Products
10.2 How to Apply for Orphan Designation in Europe
10.3 Marketing Authorization & Market Exclusivity
10.4 Transferring an Orphan Designation to another Sponsor
10.5 Mandatory Submission of Annual Report On Development
10.6 Incentives for Micro, Small and Medium-Sized Enterprises
10.7 Fee Reductions for Designated Orphan Medicinal Products
10.8 Procedure for Orphan Designation & Incentives for R&D (Regulation (EC) No 141/2000)
11. Asian Regulations for Clinical Trials of Orphan Designated Drugs
11.1 Taiwan Rare Disease and Orphan Drug Act
11.2 Japan Orphan Drug Regulation
12. Global Orphan Drugs Clinical Pipeline Insight & Patent Analysis by Company, Country, Indication & Phase
12.1 Unknown
12.2 Research
12.3 Preclinical
12.4 Clinical
12.5 Phase-I
12.6 Phase-I/II
12.7 Phase-II
12.8 Phase-II/III
12.9 Phase-III
12.10 Preregistration
12.11 Registered
13. Marketed Orphan Drugs Clinical Insight & Patent Analysis by Company, Country & Indication
14. Discontinued & Suspended Orphan Drugs in Clinical Trials
14.1 No Development Reported
14.2 Discontinued
14.3 Preregistration-Submission Withdrawal
14.4 Market Withdrawal
14.5 Suspended
15. Competitive Landscape
15.1 AOP Orphan
15.2 Agenus
15.3 Alexion
15.4 Bristol Myers Squibb
15.5 Biogen Idec
15.6 Celgene
15.7 Eli Lilly
15.8 Genethon
15.9 Genzyme Corporation
15.10 Glaxosmithkline
15.11 Merck
15.12 Novartis Pharmaceuticals
15.13 Orphan Europe
15.14 Pfizer
15.15 Prosensa
15.16 Rare Disease Therapeutics
15.17 Roche
15.18 Sanofi
15.19 Shire
15.20 Teva Pharmaceutical
【レポート販売概要】
■ タイトル:希少疾病用医薬品の世界市場動向■ 英文:Global Orphan Drug Market Future Outlook 2020
■ 発行日:2015年6月
■ 調査会社:KuicK Research
■ 商品コード:KUIK506191
■ 調査対象地域:グローバル
- 医療用ロボットが転換するヘルスケア市場:価格、費用対効果分析、医療費償還、選定基準、購買サイクルMedical robots are increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the ad …
- 乳児用フォーミュラのアジア太平洋市場:種類別(乳児用調製乳、フォローオンミルク、特殊ベビーミルク、グローイングアップミルク)、成分別(炭水化物、脂肪、タンパク質、ミネラル、ビタミン、その他)、流通経路別(ハイパーマーケット、スーパーマーケット、薬局/医療店 、専門店、ディスカウントストア、eコマース、その他)Nutrition is one of the most significant factors that influences a child’s development and growth. The baby infant formula market comprises a diversified range of products from various infant formulas to baby food products. Baby infant formula is produced for feeding babies and infants, which are usually under 12 month of age and also it is prepared from liquid or powder. Baby infant formula facil …
- CK-MBの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of CK-MB testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/D …
- 医療機器業界のM&A及び投資動向(四半期別):Q4 2012Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends – Q4 2012 Summary GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends – Q4 2012” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financing in the medical equipment market. The report provides detailed information on M&As, equity/debt offerings, p …
- LTE端末データベース:ベンダー、出荷量、売上、加入者数(LTE Devices Database: Vendor Device Launches, Shipments, Revenues & Subscriptions by Region and Country: 2011-2015)LTE device shipments reached 8 million units at the end of 2011. With most vendors going full swing into the LTE, the LTE devices market is set to grow at a CAGR of over 104 % over the next five years reaching 300 million shipments by 2016. 2012 alone will see shipments increase to 32 million units. From a regional perspective North America will continue to lead the market in terms of shipments. H …
- ソーラーファーム自動化の世界市場2016-2020About Solar Farm Automation A solar tracker is a device used to orient a solar panel or align a solar reflector or lens toward the sun. It ensures that the solar modules remain in the best position to harness the maximum energy from the sun. A solar tracker is bound to the panel so that the position of the latter can be changed based on the sun's position throughout the year. Solar tracking is an …
- 先進パッケージング・ソリューションの世界市場2015-2019Technavio’s market research analysts predict the global advanced packaging market to grow at a CAGR of close to 8% until 2019. To calculate the market size, analysts have considered revenues generated by global advanced packaging solution providers. The market is segmented according to the technology offered by the major players and on the basis of geography. The global advanced packaging market c …
- ソフトウェア定義(SDx)の世界市場予測(~2024年)Increasing big data generation by enterprises and their increasing demand for virtualization and cloud in data centers to drive the market growth of SDx solutionsThe global Software-Defined Anything (SDx) market size is expected to grow from 51.7 billion in 2019 to USD 160.8 by 2024, at a Compound Annual Growth Rate (CAGR) of 25.5% during the forecast period. Organizations worldwide are increasing …
- 歯内用品の世界市場:種類別、地域別Global Endodontic Supplies Market: About this market Technavio’s endodontic supplies market analysis considers sales from endodontic burs and obturators, endodontic scalers, and endodontic files. Our study also finds the sales of endodontic supplies in Asia, Europe, North America, and ROW. In 2019, the endodontic burs and obturators segment had a significant market share, and this trend is expecte …
- グローバル個人衛生用品市場におけるM&A動向(2014年3月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global personal hygiene market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global personal hygiene market throughout the month. Additionally, the report provides an overview of …
- 脳モニタリングの世界市場予測(~2021年):MRI、CT、PET、EEG、EMG、MEG、TCD、ICP、電極、センサ、ゲル、ケーブルThe global brain monitoring market is expected to reach USD 12.22 Billion by 2021 from USD 8.80 Billion in 2016, growing at a CAGR of 6.8% from 2016 to 2021. The increasing incidence of neurological disorders, rising awareness about neurodegenerative diseases, growth in the number of traumatic brain injuries, and technological advancements are major factors driving the demand for brain monitoring …
- 細胞表面マーカーの世界市場予測(~2023年)“High global prevalence of cancer is expected to drive the overall growth of the cell surface markers market”The cell surface markers market is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1% during the forecast period. The growth of this market is majorly driven by the high global prevalence of cancer, increasing funding for life sciences research, and g …
- 世界における国境警備市場動向(2014-2024)The global border security market is currently undergoing an unprecedented boom period as a result of a ‘virtuous circle’ that has recently formed and will be driving spending for some time. This dynamic is fuelled by three interlocking developments. First, there are increased pressures and risks impacting national borders, such as illegal immigration or terrorist infiltration. Second, more financ …
- フライングカーの世界市場2018-2022118 pages, November 2018 About this market Increasing traffic congestion is emerging as an inescapable condition in certain large and metropolitan cities worldwide from Los Angles to Tokyo and New Delhi to London. Traffic congestion is a serious issue, particularly in countries such as India, China and Vietnam that are witnessing an unprecedented growth in urban traffic and the consequent traffic …
- ペクチンの世界市場2017-2021About Pectin Pectin was first discovered in 1790 by the French chemist Louis Nicola Vauquelin. He was able to separate from fruit juice, a water-soluble substance that turns liquids into a gel. The name pectin is derived from the Greek word “pektos” that means curdling or congealing. The beneficial properties of pectin were discovered immediately even before its chemical composition was determined …